Chapter 16. Acinetobacter spp.

  1. Stephen H. Gillespie3,
  2. Peter M. Hawkey4
  1. Peter Hawkey1,4,
  2. Eugenie Bergogne-Berezin2

Published Online: 7 DEC 2006

DOI: 10.1002/9780470017968.ch16

Book Title

Principles and Practice of Clinical Bacteriology, Second Edition

Principles and Practice of Clinical Bacteriology, Second Edition

Additional Information

How to Cite

Hawkey, P. and Bergogne-Berezin, E. (2006) Acinetobacter spp., in Principles and Practice of Clinical Bacteriology, Second Edition (eds S. H. Gillespie and P. M. Hawkey), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9780470017968.ch16

Editor Information

  1. 3

    Centre for Medical Microbiology, Royal Free and University College Medical School, Hampstead Campus, Rowland Hill Street, London NW3 2PF, UK

  2. 4

    Division of Immunity and Infection, The Medical School, Edgbaston, Birmingham B15 2TT, UK

Author Information

  1. 1

    Health Protection Agency, Birmingham Heartlands Hospital, Birmingham, UK

  2. 2

    University Paris 7, Faculty of Medicine Bichat, 100 bis rue du Cherche-Midi, Paris 75006, France

  3. 4

    Division of Immunity and Infection, The Medical School, Edgbaston, Birmingham B15 2TT, UK

Publication History

  1. Published Online: 7 DEC 2006
  2. Published Print: 20 JAN 2006

ISBN Information

Print ISBN: 9780470849767

Online ISBN: 9780470017968

SEARCH

CHAPTER TOOLS

Get PDF (519K)

Keywords:

  • Acinetobacter spp.;
  • Bacillus alcaligenes faecalis;
  • respiratory tract infections;
  • single drug versus combination therapy;
  • chryseobacterium (flavobacterium)

Summary

This chapter contains sections titled:

  • Introduction

  • Acinetobacter

  • Clinical Features of Acinetobacter Infections

  • Laboratory Diagnosis

  • Treatment

  • Other Aerobic Gram-Negative Bacilli

  • Introduction

  • Stenotrophomonas Maltophilia (Previously Xanthomonas)

  • Chryseobacterium (Previously Flavobacterium)

  • Alcaligenes

  • Miscellaneous Aerobic Gram-Negative Bacilli

  • References

Get PDF (519K)